Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
The group's activity appears highly profitable thanks to its outperforming net margins.
This company will be of major interest to investors in search of a high dividend stock.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Sales forecast by analysts have been recently revised upwards.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Analyst opinion has improved significantly over the past four months.
Considering the small differences between the analysts' various estimates, the group's business visibility is good.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses: Omega Healthcare Investors, Inc.
The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
With a 2024 P/E ratio at 25.11 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
The company's "enterprise value to sales" ratio is among the highest in the world.
The group usually releases earnings worse than estimated.